On 5 March 2026, Biomemory announced it had acquired the assets of Catalog Technologies, a Boston-based pioneer in DNA data storage and computing, in a deal whose financial terms were not disclosed. Biomemory said the acquisition expands its intellectual-property portfolio to more than 90 patents and brings Catalog’s experts, Boston office, and production/R&D footprint under its control, with first commercial solutions targeted for the second half of 2026.
Technically, the transaction combines Biomemory’s industrial DNA storage architecture with Catalog’s foundational work in DNA information processing, including printing, reading, search, and computing. For lunar infrastructure, the strategic value is not ordinary storage capacity but extreme archival density and power efficiency: if this platform reaches reliable deployment, it could support century-scale backups, immutable records, and low-energy cold storage for mission-critical civilizational data.
Ark team action: monitor whether Biomemory meets its H2 2026 commercial timeline, whether the Boston hub materially improves throughput and error rates, and whether any deployed system demonstrates durable read/write economics at scale. Prioritize technical scouting for radiation-hardened packaging, error-correction protocols, and hybrid archives that pair DNA with conventional memory for Lunar Ark preservation layers.